ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT05404139 updates: 1. completion date: 2026-03-01 → 2031-02-01 2. primary completion date: 2026-03-01 → 2031-02-01
Clinical trial NCT05404139 updates: 1. completion date: 2026-03-01 → 2031-02-01 2. primary completion date: 2026-03-01 → 2031-02-01
Clinical trial NCT04516369 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-22 → 2026-05-19
Clinical trial NCT07216573: start date: 2026-04-01 → 2026-05-07.
Clinical trial NCT05777031 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 22 → 12 participants 3. enrollment type: ESTIMATED → ACTUAL 4. collaborators added: Endo USA Inc., a Keenova Therapeutics Company 5. collaborators removed: Endo Pharmaceuticals
Clinical trial NCT04380350 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-03-30 → 2026-02-12 3. primary completion date: 2026-09-30 → 2026-02-12
National HealthCare Corporation Acquires Five Skilled Nursing Facilities in Strategic $50,500,000 Transaction
Clinical trial NCT06693960 updates: 1. completion date: 2025-12-31 → 2027-01-31 2. primary completion date: 2025-09-15 → 2026-12-15
Clinical trial NCT07112508 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-01-01 → 2026-04-01 3. completion date: 2027-01-01 → 2027-11-01 4. primary completion date: 2026-09-30 → 2026-06-01
Clinical trial NCT03907176 updates: 1. start date: 2019-04-05 → 2019-04-04 2. enrollment: 115 → 209 participants
Clinical trial NCT06089291 updates: 1. status: ENROLLING_BY_INVITATION → ACTIVE_NOT_RECRUITING 2. completion date: 2027-12-01 → 2026-12-01